Pierce, Carrie E.
de Vries, Sieta T.
Bodin-Parssinen, Stephanie
Härmark, Linda
Tregunno, Phil
Lewis, David J.
Maskell, Simon
Van Eemeren, Raphael
Ptaszynska-Neophytou, Alicia
Newbould, Victoria
Dasgupta, Nabarun
Wisniewski, Antoni F. Z.
Gama, Sara
Mol, Peter G. M.
Funding for this research was provided by:
Innovative Medicines Initiative (115632)
Article History
First Online: 25 March 2019
Compliance with Ethical Standards
:
: The WEB-RADR project has received support from the Innovative Medicine Initiative Joint Undertaking (http://www.imi.europa.eu) under Grant Agreement no 115632, resources of which are composed of financial contributions from the European Union’s Seventh Framework Programme (FP7/2007-2013) and EFPIA companies’ in-kind contribution.
: The following authors have declared no potential conflicts of interest: Sieta T. de Vries, Stephanie Bodin-Parssinen, Linda Härmark, Phil Tregunno, Simon Maskell, Raphael Van Eemeren, Alicia Ptaszynska-Neophytou, Victoria Newbould, Nabarun Dasgupta, and Peter G.M. Mol. Carrie Pierce is an employee of Booz Allen Hamilton, formerly Epidemico Inc.; David Lewis is an employee of Novartis Pharma AG and is a shareholder in Novartis and GlaxoSmithKline; Antoni Wisniewski is an employee of AstraZeneca and shareholder of AstraZeneca and GlaxoSmithKline; Sara Gama is an employee of Novartis Pharma AG.